Dextromethorphan inhibits activations and functions in dendritic cells

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Chen, Der Yuan ^a,b,c   Song, Pei Shan ^a   Hong, Jau Shyong ^d   Chu, Ching Liang ^e   Pan, I Horng ^f   Chen, Yi Ming ^b,c   Lin, Ching Hsiung ^g,h,i   Lin, Sheng Hao ^a,g   Lin, Chi Chen ^a,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^h CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

ⁱ CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; DEXTROMETHORPHAN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; ANTITUSSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; FEMALE; MIXED LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTITUSSIVE AGENTS; CELLS, CULTURED; DENDRITIC CELLS; DEXTROMETHORPHAN; FEMALE; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84879323730     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/125643     Document Type: Article

References (59)

1. Steinman R. M., Hemmi H., Dendritic cells: translating innate to adaptive immunity. Current Topics in Microbiology and Immunology 2006 311 17 58 2-s2.0-33750934617
2. Lipscomb M. F., Masten B. J., Dendritic cells: immune regulators in health and disease. Physiological Reviews 2002 82 1 97 130 2-s2.0-0036086102
3. Thomas R., Lipsky P. E., Dendritic cells: origin and differentiation. Stem Cells 1996 14 2 196 206 2-s2.0-0029892039
4. Watts C., West M. A., Zaru R., TLR signalling regulated antigen presentation in dendritic cells. Current Opinion in Immunology 2010 22 1 124 130 2-s2.0-77249145443 10.1016/j.coi.2009.12.005
5. Yanagawa Y., Iijima N., Iwabuchi K., Onoé K., Activation of extracellular signal-related kinase by TNF- α controls the maturation and function of murine dendritic cells. Journal of Leukocyte Biology 2002 71 1 125 132 2-s2.0-0036141344
6. Hubert P., Jacobs N., Caberg J. H., Boniver J., Delvenne P., The cross-talk between dendritic and regulatory T cells: good or evil? Journal of Leukocyte Biology 2007 82 4 781 794 2-s2.0-34848832026 10.1189/jlb.1106694
7. Thompson A. G., Thomas R., Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease. Immunology and Cell Biology 2002 80 6 509 519 2-s2.0-0036431735 10.1046/j.1440-1711.2002.01114.x
8. Menges M., Rößner S., Voigtländer C., Schindler H., Kukutsch N. A., Bogdan C., Erb K., Schuler G., Lutz M. B., Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. Journal of Experimental Medicine 2002 195 1 15 21 2-s2.0-0037033427 10.1084/jem.20011341
9. Roelen D. L., Schuurhuis D. H., van den Boogaardt D. E. M., Koekkoek K., Van Miert P. P. M. C., Van Ŝchip J. J., Laban S., Rea D., Melief C. J. M., Offringa R., Ossendorp F., Claas F. H. J., Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 2003 76 11 1608 1615 2-s2.0-10744221193 10.1097/01.TP.0000086340.30817.BA
10. Elftman M. D., Norbury C. C., Bonneau R. H., Truckenmiller M. E., Corticosterone impairs dendritic cell maturation and function. Immunology 2007 122 2 279 290 2-s2.0-34548596997 10.1111/j.1365-2567.2007.02637.x
11. Wang Z. Y., Morinobu A., Kawano S., Saegusa J., Wang B., Kumagai S., Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes. Clinical and Experimental Rheumatology 2002 20 5 683 688 2-s2.0-0036709080
12. Kirsch B. M., Zeyda M., Stuhlmeier K., Grisar J., Smolen J. S., Watschinger B., Stulnig T. M., Hörl W. H., Zlabinger G. J., Säemann M. D., The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function. Arthritis research & therapy 2005 7 3 R694 R703 2-s2.0-33644808414
13. Wadia P. P., Herrera N. D., Abecassis M. M., Tambur A. R., Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells. Human Immunology 2009 70 9 692 700 2-s2.0-68749095717 10.1016/j.humimm.2009.05. 002
14. Frikeche J., Simon T., Brissot E., Grégoire M., Gaugler M Mohty B., Impact of valproic acid on dendritic cells function. Immunobiology 2012 217 7 704 710
15. Frikeche J., Peric Z., Brissot E., Grégoire M., Gaugler B., Mohty M., Impact of HDAC inhibitors on dendritic cell functions. Experimental Hematology 2012 40 10 783 791
16. Wang C. C., Lee Y. M., Wei H. P., Chu C. C., Yen M. H., Dextromethorphan prevents circulatory failure in rats with endotoxemia. Journal of Biomedical Science 2004 11 6 739 747 2-s2.0-10844281765 10.1159/000081820
17. Chechneva O. V., Mayrhofer F., Daugherty D. J., Pleasure D. E., Hong J. S., Deng W., Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiology of Disease 2011 44 1 63 72 2-s2.0-79961128957 10.1016/j.nbd.2011.06.004
18. Li M. H., Luo Y. H., Lin C. F., Chang Y. T., Lu S. L., Kuo C. F., Hong J. S., Lin Y. S., Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis. Antimicrobial Agents and Chemotherapy 2011 55 3 967 973 2-s2.0-79952321922 10.1128/AAC.00950-10
19. Liu S. L., Li Y. H., Shi G. Y., Tang S. H., Jiang S. J., Huang C. W., Liu P. Y., Hong J. S., Wu H. L., Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovascular Research 2009 82 1 161 169 2-s2.0-62349119913 10.1093/cvr/cvp043
20. Liu P. Y., Lin C. C., Tsai W. C., Li Y. H., Lin L. J., Shi G. Y., Hong J. S., Chen J. H., Wu H. L., Treatment with dextromethorphan improves endothelial function, inflammation and oxidative stress in male heavy smokers. Journal of Thrombosis and Haemostasis 2008 6 10 1685 1692 2-s2.0-52449084260 10.1111/j.1538-7836.2008.03082.x
21. Wang S. T., Chang C. C., Yen M. C., Tu C. F., Chu C. L., Peng Y. T., Chen D. Y., Lan J. L., Lin C. C., RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency. Gene Therapy 2011 18 4 372 383 2-s2.0-79953800932 10.1038/gt.2010.146
22. Lin C. C., Yu Y. L., Shih C. C., Liu K. J., Ou K. L., Hong L. Z., Chen J. D. C., Chu C. L., A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunology, Immunotherapy 2011 60 7 1019 1027 2-s2.0-79959743488 10.1007/s00262-011-1016-4
23. Wu C. S., Chen Y. J., Chen J. J., Shieh J. J., Huang C. H., Lin P. S., Chang G. C., Chang J. T., Lin C. C., Terpinen-4-ol induces apoptosis in human nonsmall cell lung cancer in vitro and in vivo. Evidence-Based Complementary and Alternative Medicine 2012 2012 13 818261 10.1155/2012/818261
24. Steinman R. M., Banchereau J., Taking dendritic cells into medicine. Nature 2007 449 7161 419 426 2-s2.0-34848837386 10.1038/nature06175
25. Verhasselt V., Vanden Berghe W., Vanderheyde N., Willems F., Haegeman G., Goldman M., N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF- B inhibition. Journal of Immunology 1999 162 5 2569 2574 2-s2.0-0033106338
26. Rescigno M., Martino M., Sutherland C. L., Gold M. R., Ricciardi-Castagnoli P., Dendritic cell survival and maturation are regulated by different signaling pathways. Journal of Experimental Medicine 1998 188 11 2175 2180 2-s2.0-0031775746 10.1084/jem.188.11.2175
27. Arrighi J. F., Rebsamen M., Rousset F., Kindler V., Hauser C., A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF- α and contact sensitizers. Journal of Immunology 2001 166 6 3837 3845 2-s2.0-0035869634
28. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., Liu S., Wang W., Guo Z., Guo J., Qin Z., Cao X., Involvement of ERK, p38 and NF- B signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002 106 1 38 45 2-s2.0-0036235478 10.1046/j.1365-2567.2002.01401.x
29. Kawai T., Akira S., Signaling to NF- B by Toll-like receptors. Trends in Molecular Medicine 2007 13 11 460 469
30. Jiang S. J., Hsu S. Y., Deng C. R., Huang H. C., Liu S. L., Shi G. Y., Wu H. L., Dextromethorphan attenuates LPS-induced adhesion molecule expression in human endothelial cells. Microcirculation 2013 20 2 190 201
31. Brown J., Wang H., Hajishengallis G. N., Martin M., TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of Dental Research 2011 90 4 417 427 2-s2.0-79954577277 10.1177/0022034510381264
32. Oeckinghaus A., Hayden M. S., Ghosh S., Crosstalk in NF- B signaling pathways. Nature Immunology 2011 12 8 695 708
33. Luo J. L., Kamata H., Karin M., The anti-death machinery in IKK/NF- B signaling. Journal of Clinical Immunology 2005 25 6 541 550 2-s2.0-29444453188 10.1007/s10875-005-8217-6
34. Thannickal V. J., Fanburg B. L., Reactive oxygen species in cell signaling. The American Journal of Physiology 2000 279 6 L1005 L1028 2-s2.0-0034533082
35. Wu T. C., Chao C. Y., Lin S. J., Chen J. W., Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension. PLoS One 2012 7 9 e46067
36. Li G., Cui G., Tzeng N. S., Wei S. J., Wang T., Block M. L., Hong J. S., Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB Journal 2005 19 6 489 496 2-s2.0-16344374513 10.1096/fj.04-2555com
37. Zhang W., Wang T., Qin L., Gao H. M., Wilson B., Ali S. F., Zhang W., Hong J. S., Liu B., Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB Journal 2004 18 3 589 591 2-s2.0-2442693172
38. Song J. H., Yeh J. Z., Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells. Neuroscience Letters 2012 516 1 94 98
39. Savina A., Jancic C., Hugues S., Guermonprez P., Vargas P., Moura I. C., Lennon-Duménil A. M., Seabra M. C., Raposo G., Amigorena S., NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006 126 1 205 218 2-s2.0-33745825951 10.1016/j.cell.2006.05.035
40. Vulcano M., Dusi S., Lissandrini D., Badolato R., Mazzi P., Riboldi E., Borroni E., Calleri A., Donini M., Plebani A., Notarangelo L., Musso T., Sozzani S., Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. Journal of Immunology 2004 173 9 5749 5756
41. Zhu J., Yamane H., Paul W. E., Differentiation of effector CD4+ T cell populations. Annual Review of Immunology 2010 28 445 489 2-s2.0-77952313777 10.1146/annurev-immunol-030409-101212
42. Watford W. T., Moriguchi M., Morinobu A., O'Shea J. J., The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine and Growth Factor Reviews 2003 14 5 361 368 2-s2.0-0042375986 10.1016/S1359-6101(03)00043-1
43. Schroder K., Hertzog P. J., Ravasi T., Hume D. A., Interferon- γ: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology 2004 75 2 163 189 2-s2.0-0842266786 10.1189/jlb.0603252
44. Moss R. B., Moll T., El-Kalay M., Kohne C., Hoo W. S., Encinas J., Carlo D. J., Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opinion on Biological Therapy 2004 4 12 1887 1896 2-s2.0-10344220475 10.1517/14712598.4.12.1887
45. Barton G. M., Medzhitov R., Control of adaptive immune responses by Toll-like receptors. Current Opinion in Immunology 2002 14 380 383
46. Hammad H., Smits H. H., Ratajczak C., Nithiananthan A., Wierenga E. A., Stewart G. A., Jacquet A., Tonnel A. B., Pestel J., Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. European Cytokine Network 2003 14 4 219 228 2-s2.0-1642457392
47. Galy A., Christopherson I., Ferlazzo G., Liu G., Spits H., Georgopoulos K., Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. Blood 2000 95 1 128 137 2-s2.0-0033966367
48. Orabona C., Grohmann U., Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond. Methods in Molecular Biology 2011 677 269 280 2-s2.0-79952201446
49. Chung D. J., Rossi M., Romano E., Ghith J., Yuan J., Munn D. H., Young J. W., Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009 114 3 555 563 2-s2.0-70149093957 10.1182/blood-2008-11-191197
50. Kushwah R., Hu J., Role of dendritic cells in the induction of regulatory T cells. Cell and Bioscience 2011 1 1 1 20
51. Levings M. K., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., Roncarolo M. G., Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005 105 3 1162 1169 2-s2.0-12844274909 10.1182/blood-2004-03-1211
52. Haase C., Jørgensen T. N., Michelsen B. K., Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology 2002 107 4 489 499 2-s2.0-0037945448 10.1046/j.1365-2567.2002.01529.x
53. Bai A., Lu N., Guo Y., Liu Z., Chen J., Peng Z., All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. Journal of Leukocyte Biology 2009 86 4 959 969 2-s2.0-70349635629 10.1189/jlb.0109006
54. Banchereau J., Pascual V., 'Garra A. O., From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nature Immunology 2012 13 10 925 931
55. Capon D. A., Bochner F., Kerry N., Mikus G., Danz C., Somogyi A. A., The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Clinical Pharmacology and Therapeutics 1996 60 3 295 307 2-s2.0-0029853347 10.1016/S0009-9236(96)90056-9
56. Steinberg G. K., Bell T. E., Yenari M. A., Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients. Journal of Neurosurgery 1996 84 5 860 866 2-s2.0-0029876331
57. Colonna M., Pulendran B., Iwasaki A., Dendritic cells at the host-pathogen interface. Nature Immunology 2006 7 2 117 120 2-s2.0-31344453421 10.1038/ni0206-117
58. Manickam A., Sivanandham M., Tourkova I. L., Immunological role of dendritic cells in cervical cancer. Advances in Experimental Medicine and Biology 2007 601 155 162
59. Pulendran B., Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunologic Research 2004 29 1-3 187 196